Lentiviral vectors escape innate sensing but trigger p53 in human hematopoietic stem and progenitor cells
Abstract Clinical application of lentiviral vector (LV)‐based hematopoietic stem and progenitor cells (HSPC) gene therapy is rapidly becoming a reality. Nevertheless, LV‐mediated signaling and its potential functional consequences on HSPC biology remain poorly understood. We unravel here a remarkabl...
Main Authors: | Francesco Piras, Michela Riba, Carolina Petrillo, Dejan Lazarevic, Ivan Cuccovillo, Sara Bartolaccini, Elia Stupka, Bernhard Gentner, Davide Cittaro, Luigi Naldini, Anna Kajaste‐Rudnitski |
---|---|
Format: | Article |
Language: | English |
Published: |
Springer Nature
2017-06-01
|
Series: | EMBO Molecular Medicine |
Subjects: | |
Online Access: | https://doi.org/10.15252/emmm.201707922 |
Similar Items
-
Transduction of hematopoietic stem and progenitor cells by an MECP2 lentiviral vector improves Rett syndrome phenotypes
by: Joseph S. Anderson, et al.
Published: (2025-02-01) -
Harnessing lentiviral vectors for in vivo gene therapy of liver metastases
by: Giovanna Giacca, et al.
Published: (2024-01-01) -
Genetic engineering of hematopoiesis: current stage of clinical translation and future perspectives
by: Luigi Naldini
Published: (2019-01-01) -
Comparison Between Several Integrase-defective Lentiviral Vectors Reveals Increased Integration of an HIV Vector Bearing a D167H Mutant
by: Muhammad Qamar Saeed, et al.
Published: (2014-01-01) -
Genome editing for scalable production of alloantigen‐free lentiviral vectors for in vivo gene therapy
by: Michela Milani, et al.
Published: (2017-08-01)